SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
82 hedge funds and large institutions have $67.8M invested in Seelos Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Holders
82
Holding in Top 10
–
Calls
$4.51M
Puts
$220K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.18M | |
| 3 | +$545K | |
| 4 |
Morgan Stanley
New York
|
+$415K |
| 5 |
BlackRock
New York
|
+$361K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$964K | |
| 3 | -$722K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$660K |
| 5 |
Two Sigma Advisers
New York
|
-$599K |